Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 6/20 | 0.42 |
| ▸ | XDH | P47989 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aucubin SCHEMBL22680275 | 1.00 | L3MBTL1 (1.00) | L3MBTL1HSP90AA1XDHELANEPTPN1 | |
| Aucubin SCHEMBL22680274 | 1.00 | L3MBTL1 (1.00) | L3MBTL1HSP90AA1XDHELANEPTPN1 | |
| SCHEMBL30558037 | 0.86 | L3MBTL1 (0.75) | L3MBTL1HSP90AA1XDHMEN1KMT2A | |
| SCHEMBL421128 | 0.83 | L3MBTL1 (0.70) | L3MBTL1HSP90AA1ELANEPTPN1 | |
| Agnuside SCHEMBL24174405 | 0.81 | L3MBTL1 (0.67) | L3MBTL1HSP90AA1XDH | |
| Agnuside SCHEMBL382107 | 0.81 | L3MBTL1 (0.67) | L3MBTL1HSP90AA1XDH | |
| SCHEMBL7153129 | 0.81 | L3MBTL1 (0.67) | L3MBTL1HSP90AA1XDHPTPN1 | |
| Agnuside SCHEMBL13208121 | 0.81 | L3MBTL1 (0.67) | L3MBTL1HSP90AA1XDH | |
| SCHEMBL2989887 | 0.78 | L3MBTL1 (0.64) | L3MBTL1HSP90AA1PTPN1 | |
| SCHEMBL13461206 | 0.78 | L3MBTL1 (0.64) | L3MBTL1ELANEPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3339 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107262-A1 | PROLONGED, SCAFFOLD-MEDIATED DELIVERY OF ANGIOGENIC COMPOUNDS | EFEMORAL MEDICAL, INC. (US) | 2026-05-21 | — | — | WO | claimed |
| US-20260096314-A1 | DISPLAY DEVICE AND ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2026-04-02 | — | — | US | claimed |
| WO-2026046628-A1 | CATALYTIC ARRANGEMENT FOR A LASER SYSTEM, IN PARTICULAR CONFIGURED TO PROVIDE A DRIVE LASER IN AN EUV LITHOGRAPHIC SYSTEM | ASML NETHERLANDS B.V. (NL) | 2026-03-05 | — | — | WO | claimed |
| EP-4703799-A1 | CATALYTIC ARRANGEMENT WITH DIFFUSION PREVENTION FOR A LASER SYSTEM, IN PARTICULAR OF A DRIVE LASER IN AN EUV LITHOGRAPHIC SYSTEM | ASML Netherlands B.V. (NL) | 2026-03-04 | — | — | EP | claimed |
| EP-4694699-A2 | COMPOSITIONS AND METHODS OF CONTROLLING MAMMALIAN SATIETY | VitaKey Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| US-20260021152-A1 | USE OF MALE FLOWER EXTRACT OF EUCOMMIA ULMOIDES OLIVER IN PREPARATION OF FOOD OR MEDICAMENT FOR RESISTING MUSCLE AGING | UNIV ZHEJIANG (CN) | 2026-01-22 | — | — | US | claimed |
| US-12424594-B2 | Integrated diamond substrate for thermal management | RAYTHEON COMPANY (US) | 2025-09-23 | — | — | US | claimed |
| US-20250291107-A1 | Hollow Core Optical Waveguiding Enabled by Zero-Index Materials | UNIV CALIFORNIA (US) | 2025-09-18 | — | — | US | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| EP-3996814-B1 | USE OF A HERBAL EXTRACT COMPRISING VERBASCOSIDE AND AUCUBIN FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE | LABIOTRE S R L (IT) | 2025-09-17 | — | — | EP | claimed |
| CN-1400299-A | Method for continuously extracting eucommia oil and aucuboside from eucommia seed | ZHANG KANGJIAN (CN) | 2003-03-05 | — | — | CN | claimed |
| WO-2001001996-A9 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIV WESTERN AUSTRALIA (AU) | 2002-09-12 | — | — | WO | claimed |
| US-6242012-B1 | Herbal composition for promoting hormonal balance in women and methods of using same | NEW CHAPTER, INC. | 2001-06-05 | — | — | US | claimed |
| EP-1102602-A1 | CONTACT LENS AND OPHTHALMIC SOLUTIONS | NDT, Inc. (US) | 2001-05-30 | — | — | EP | claimed |
| WO-2001001996-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2001-01-11 | — | — | WO | claimed |
| US-6162393-A | Contact lens and ophthalmic solutions | NDT, INC. (US) | 2000-12-19 | — | — | US | claimed |
| WO-2000007634-A1 | CONTACT LENS AND OPHTHALMIC SOLUTIONS | NDT, INC. (US) | 2000-02-17 | — | — | WO | claimed |
| CN-1047307-C | Pharmaceutical compositions for the treatment of hepatitis B virus (HBV) infection | CHANG IL MOO (KR) | 1999-12-15 | — | — | CN | claimed |
| US-5929038-A | ADMINISTERING IRIDOID COMPOUNDS | CHOONGWAE PHARMACEUTICAL CO., LTD. (KR) | 1999-07-27 | — | — | US | claimed |
| CN-1082895-A | The Pharmaceutical composition that treatment hepatitis B virus (HBV) infects | CHOONGWAE PHARMA CO LTD (KR) | 1994-03-02 | — | — | CN | claimed |